FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 357:504-506 August 2, 2007 Number 5 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by The American Lung Association Asthma Clinical Research Centers PubMed Citation

To the Editor: The study by the American Lung Association Asthma Clinical Research Centers (May 17 issue)¹ showed that for patients with mild persistent asthma who were receiving twice-daily fluticasone, switching to treatment with once-daily fluticasone plus salmeterol was as effective as continuing treatment with twice-daily fluticasone. Asthma control often worsens over time because compliance with a twice-daily medication regimen decreases, which is an impetus for once-daily treatment. Since all participants used inhalers twice daily in this study, the findings do not allow one to determine whether once-daily treatment improves compliance and leads to better control. To determine whether once-daily . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.